Top Injectable Manufacturer in Brunei – Reliable Pharmaceutical Solutions
Last Updated: September 14, 2026
TL;DR: Brunei Darussalam's governing instrument is the Medicines Order, 2007, and product registration has been mandatory since July 2012 — but we found no reference-country list published by the authority itself. The benchmark list that circulates comes from a trade guide, and India is not among the countries it names, so India's absence is reported rather than verified. The best-evidenced requirement is the import licence: the applicant must be a company registered in Brunei Darussalam with a locally based responsible person, valid one year. Dossiers are built to ACTD, which buys format reusability and not GMP recognition.
Key Takeaways
We found no reference-country or reference-agency list on the Ministry of Health's own product registration pages. A benchmark list naming Singapore, Malaysia, Australia, Canada, the EU centralised procedure, the United States and the United Kingdom is reported by a trade guide rather than published by the authority, and India is not among the countries named.
Registration dossiers follow the ASEAN Common Technical Dossier and ASEAN Common Technical Requirements. ACTD competence buys dossier-format reusability; it does not buy GMP recognition, an inspection waiver or an abridged evaluation.
The gate is the importer. The Department of Pharmaceutical Services' own import licence guideline states that any company registered under the Registry of Companies and Business Names in Brunei Darussalam is eligible to apply, and must authorise a responsible person based in Brunei Darussalam. Import and wholesaler licences are each valid one year.
On halal we found no source stating that certification is a precondition for importing a non-orally-consumed medicine into Brunei Darussalam, but we could not read the 2017 amending Order that would settle it, so we treat the question as open.
Introduction: What an Injectable Manufacturer in Brunei Has to Clear
Brunei Darussalam is a small market by population but an unusually concentrated one, and on the sources we read the practical entry question is less about the foreign site than about which locally registered company holds the import licence a product would sit on.
The governing instrument is the Medicines Order, 2007, gazetted as S 79/07, and on the Ministry of Health's own current pharmacy page it is described as operative. The Brunei Darussalam Medicines Control Authority, BDMCA, is established under section 5 of that Order and acts through the Department of Pharmaceutical Services. We should be candid that we did not read the Order itself: both Attorney General's Chambers URLs we tried returned empty documents, so what we say about its internal structure is second-hand rather than read. The right description of its status is amended, not repealed — regulations were layered under it in 2007 and again in 2010, and we found no repealing instrument.
What Sets a World-Class Injectable Manufacturer in Brunei Apart
On the Ministry of Health's own product registration section we found no reference-country list, no reference-agency list and no generic stringent-authority clause, and the page stops there. A benchmark-country concept does appear in secondary regulatory-consultancy material, naming Singapore, Malaysia, Australia, Canada, the European Union under the centralised procedure, the United States and the United Kingdom. India is not among the countries named and CDSCO is not named at all. That list is undated and phrased as "nations like", so we cannot tell whether it is exhaustive or illustrative.
On the same trade-guide account the abridged route is restricted to products designated General Sale List, with illustrative categories running to antiseptics, lozenges, health supplements and topical preparations — none of which is a sterile injectable, so on that account the abridged shortcut would not be open to a product like ours in any event. And the WHO transitional listing for India's CDSCO is reported at maturity level three with the scope recorded as vaccines; a listing scoped to vaccines is not a listing scoped to medicines generally. We did not open the WHO list ourselves, so we report that scope rather than assert it.
Quality Systems, ACTD Format and the Halal Question
Brunei registration dossiers are built to the ASEAN Common Technical Dossier and the ASEAN Common Technical Requirements. Documentation is to be in English or Malay, and we found no reference to eCTD submission in Brunei, which suggests a paper and physical-media regime rather than an electronic one. ACTD competence buys dossier-format reusability, so that a dossier already structured to ACTD for another ASEAN market is structurally transferable and the CTD-to-ACTD conversion effort is reduced rather than eliminated. It does not buy GMP recognition, an inspection waiver, an abridged evaluation, or any relief from the local import-licence architecture.
The ASEAN Sectoral Mutual Recognition Arrangement on GMP Inspection obliges something narrower than its name suggests: on the ASEAN Secretariat's own FAQ, member states accept certificates of a Listed Inspection Service — an ASEAN member's own inspectorate accepted by the Joint Sectoral Committee — and the benefit is expressed territorially, as no need to re-audit a facility located within the territories of a Party. We found nothing extending it to inspectorates of non-ASEAN countries. On stability we found no climatic-zone table we could read that names Brunei Darussalam, so we do not assert a zone for it; what we can report is that the ASEAN stability guideline requires 30 °C at 75% relative humidity for long-term storage in climatic zone IV. ISO Class 5 filling, HPLC and GC assay, LAL endotoxin testing and Karl Fischer water determination sit underneath that evidence.
Working out whether Brunei Darussalam is reachable for your product? Talk to our regulatory team
Why Farbe Firma Is the Trusted Injectable Manufacturer in Brunei for Global Buyers
Product registration is mandatory: on the Ministry of Health's own page, since the mandatory implementation of the drug registration system in July 2012, pharmaceutical importers, wholesalers and manufacturers must register a medicinal product before it can be marketed in Brunei Darussalam. An approved product is described as receiving a Product Licence Certificate valid for five years, reported by a trade guide rather than published by the authority. On whether BDMCA registers or inspects the overseas manufacturing site, and which foreign GMP certificates it accepts, we found no BDMCA-published document addressing it in either direction.
Where the evidence is firm is the import licence. The Department of Pharmaceutical Services' import licence guideline, third edition dated October 2017 and currently published on the Ministry's website, states that any company registered under the Registry of Companies and Business Names in Brunei Darussalam is eligible to apply and must authorise a responsible person based in Brunei Darussalam. Read that precisely: the guideline gives Director, Manager, Pharmacist or Sales Manager as examples, so a pharmacist is one of four illustrations and not, on this text, a stated mandatory qualification. Import and wholesaler licences are each valid for one year, and approval to import is subject to the validity of the product's Product Licence — two clocks running at different speeds.
The importer's standing duties are where a CDMO relationship is actually tested. Under the Second Schedule duties reproduced in that guideline, a licence holder must notify the Authority of any change in the specification of the medicinal product, in any of its constituents, in its composition or in its manufacture. A change of manufacturing process on our side is therefore a notifiable event on our importer's licence, so change control has to reach across the relationship rather than stopping at our gate. A change to another company holding no existing import or wholesaler licence requires a fresh application by that company, so switching Brunei partners is a new licensing exercise rather than a transfer. As a WHO-GMP certified sterile injectable manufacturer and CDMO in Gujarat, India, exporting to more than 30 countries and working in CTD and ACTD format, that is the discipline Farbe Firma is built to supply.
Explore Farbe Firma: Products / Global Reach / About Us
Frequently Asked Questions (FAQ)
Does Brunei Darussalam recognise Indian regulatory approvals?
We found no published list of recognised foreign regulators on the Ministry of Health's own pages. A benchmark-country list reported by a trade guide names Singapore, Malaysia, Australia, Canada, the EU centralised procedure, the United States and the United Kingdom, and India is not among them. That list is undated and reported rather than published by the authority, so India's absence is reported and not verified.
Is halal certification required for injectables imported into Brunei Darussalam?
The Halal Certificate and Halal Label Order, 2005 defines "food" to include medicine expressly; but on the 2005 text we read, its application provisions are permissive and its offences attach to making a halal representation without the corresponding certificate, which is a claim-gated regime. The 2017 Amendment Order that may have changed this returned an empty document and we did not read it. The most specific account available to us, a July 2017 business-news report of a ministry briefing, states that pharmaceutical products not orally consumed may be certified but that the procedure for them is voluntary. We would treat the question as open until a Brunei-based regulatory adviser confirms it in writing.
Does the ASEAN GMP mutual recognition arrangement cover an Indian manufacturer?
On the ASEAN Secretariat's own FAQ, the recognition obligation attaches to certificates of a Listed Inspection Service, which is an ASEAN member's own inspectorate accepted by the Joint Sectoral Committee, and the no-re-audit benefit is expressed as applying to facilities located within the territories of a Party. India is not an ASEAN Member State, and we found nothing extending the Arrangement to inspectorates of non-ASEAN countries.
Who has to hold the Brunei import licence?
The Department of Pharmaceutical Services' import licence guideline states that any company registered under the Registry of Companies and Business Names in Brunei Darussalam is eligible to apply, and that the company must authorise a responsible person based in Brunei Darussalam. On whether the Product Licence holder must itself be locally incorporated we found no BDMCA-published statement either way.
How are medicines bought by the public sector in Brunei Darussalam?
On the United States International Trade Administration's February 2024 country commercial guide, individual ministries conduct their own procurement under regulations issued by the State Tender Board at the Ministry of Finance and Economy. We found no Brunei government e-procurement portal and no e-tender platform named in any source we read. The practical reading is that procurement is downstream of licensing, because only a company registered in Brunei Darussalam holding an import or wholesaler's licence may import, store and sell the product by wholesale.
Technically Reviewed By: Maulik Sudani & Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote / View Products / FAQ / Blog
Comments